baber/WOPTO huggingface dataset:
Patent CA-2485524-A1 (CA)
Title: Method for producing a high strength al-zn-mg-cu alloy
Inventor: KEIDEL CHRISTIAN JOACHIM
IPC: C22F1/053
Filed: 2003-06-11
Abstract: The present invention relates to a method for producing a high strength AI-Z n- Cu-Mg alloy with an improved fatigue crack growth resistance and a high dama ge tolerance, comprising the steps of casting an ingot with the following composition (in weight percent) Zn 5.5- 9.5, Cu 1.5 - 3.5, Mg 1.5 - 3.5, Mn < 0.25, Zr < 0.25, Cr < 0.10, Fe < 0.25, Si < 0.25, Ti < 0.10, Hf and/or V < 0.25, other elements each less than 0.05 and less than 0.15 in total, balanc e aluminium, homogenising and/or pre-heating the ingot after casting, hot working the ingot and optionally cold working into a worked product of more than 50 mm thickness, solution heat treating, quenching the heat treated product, and artificially aging the worked and heat-treated product, wherein the aging step comprises a first heat treatment at a temperature in a range of 105~C to 135~C for more than 2 hours and less than 8 hours and a second heat treatment at a higher temperature than 135~C but below 170~C for more than 5 hours and less than 15 hours. The product achieved by the method exhibits a compression yield strengh of at least 510 Mpa and an ST elongation at S/2 of at least 3.0 %. The invention concerns a weldable plate product of such high strength Al-Zn-Cu-Mg having a thickness of more than 50 mm and an aircraft structural member produced from such alloy.
Patent CA-2485591-A1 (CA)
Inventor: BRUNKER BRADLEY J
IPC: H05K7/20
Filed: 2003-03-11
Abstract: A self contained multiple dimming channel package (20) includes a housing (22) with a main power circuit board (66) supported on its bottom wall and a control circuit board (68) extending laterally and vertically to baffle air flow through the housing (22). A cross flow cooling fan (162) forces air through an opening (154) in the control board (68) and across power switching modules (82) and toroidal chokes (84) mounted to the main board (66). Each power switching module (82) includes a heat sink (166) with fins (122) papallel to the air flow, and the chokes (84) are mounted in rows with their central openings (160) aligned with the air flow. The power switching modules (82) include circuits (124) attached to the heat sinks with terminals (134), 136, 138) releasably plugged into mating connectors (112) on the main board (66). Circuit breaker switches (42, 46) are snapped into place in the housing (22). The front corners of the housing (22) are provided with integral mounting bracket and handle members (198).
Patent CA-2485847-A1 (CA)
Title: Glucan-based vaccines
Inventor: POLONELLI LUCIANO
IPC: A61K38/00
Filed: 2003-05-15
Abstract: Anti-glucan antibodies have been found to be protective against systemic fungal infection with C.albicans, but the protective efficacy can be inhibit ed by blocking antibodies. The invention provides an immunogenic composition comprising a glucan and a pharmaceutically acceptable carrier, characterised in that, when administered to a mammalian recipient, the composition elicits protective anti-glucan antibodies but does not elicit antibodies which inhib it the protective efficacy of the anti-glucan antibodies. The glucan may be presented on the surface of a protease-treated microbial cell or may be presented as a protein-glucan conjugate. The glucan may be substituted by a glucan mimotope, a peptidomimetic of a glucan mimotope, or nucleic acid encoding a mimotope. Anti-glucan-antibodies show broad spectrum microbicidal activity. .szlig.-glucans are preferred, particularly those containing one o r more .szlig.-1,6 linkages
Patent CA-2486505-A1 (CA)
Inventor: LAPOINTE CHRISTOPHER
IPC: G06F17/00
Filed: 2004-11-01
Abstract: A method of locating nodes in train having at least one node per car and includes enabling each node; querying each enabled node to respond during a response interval; disabling each node which responded; and re-querying the enabled nodes until no further responses are received during a response interval. The method further includes disabling the responding nodes before the expiration of the response interval if the interval is under utilized and after the expiration of the response interval if the interval is fully utilized. The method further includes determining the number of responses during a present response interval and setting the length of a subsequent response interval as a function of the determined number of responses. The number of responses may be determined for a whole interval or for a portion of the present response interval, and the length of the subsequent response interval is set based on the response rate determined for the portion of the present response interval. The subsequent response interval may be initiated before the expiration of the present response interval if a new interval length is to be set.
Patent CA-2488152-A1 (CA)
Title: Vehicular article accomodation device
Inventor: INOUE MASAHIRO
IPC: B62J9/40
Filed: 2004-11-22
Abstract: To allow, in a vehicular article accommodation device having an arrangement for allowing articles stored in a storage box to be fixedly supported thereto using fixing means causing both ends thereof to be releasably engaged with locking portions provided in the storage box, the articles to be stored and secured in the storage box by flexibly responding to possible changes, if any, in a shape and a quantity of the articles to be stored in the storage box. At least three locking portions are disposed at positions mutually away from each other in a storage box, while permitting selection of specific locking portions, with which both ends of fixing means are to be engaged.
Patent CA-2488914-A1 (CA)
Title: Heterocyclic halamine-substituted siloxanes for use in biocidal coatings and materials
Inventor: WANG JIA-WANG
IPC: C07F7/18
Filed: 2003-06-12
Abstract: Siloxane monomers and polymers functionalized by certain N-halogenated heterocyclic moieties are provided for the purpose of functionalizing surfaces or materials so as to render them biocidal upon exposure to oxidative halogen solutions. The biocidal function can be imparted either before or after bonding or adhesion to the surface or material. The biocidal surfaces and materials can then be used to inactivate pathogenic microorganisms such as bacteria, fungi, and yeasts, as well as virus particles, which can cause infectious diseases, and those microorganisms which cause noxious odors and unpleasant coloring such as mildew. Examples of surfaces and materials which can be rendered biocidal in this invention include, but are not limited to, cellulose, chitin, chitosan, synthetic fibers, glass, ceramics, plastics, rubber, cement grout, latex caulk, porcelain, acrylic films, vinyl, polyurethanes, silicon tubing, marble, metals, metal oxides, and silica.
Patent CA-2490966-A1 (CA)
Inventor: GOMEZ MATTHEW A
IPC: A61F2/958
Filed: 2004-12-20
Abstract: A device for retaining a supra pubic catheter having a moveable retainer axially moveable along the catheter.
Patent CA-2491887-A1 (CA)
Title: Modified inosine monophosphate dehydrogenases
Inventor: DORN ALLAN R
IPC: C12N15/09
Filed: 2005-01-27
Abstract: The invention relates to a modified IMPDH polypeptide wherein the IMPDH  polypeptide has a histidine tag and where the subdomain of the IMPDH polypeptide is modified so that the rate stability of the histidine-tagged, modified IMPDH polypeptide is maintained relative to the wild-type IMPDH polypeptide. The invention also relates to a method, nucleic acid molecules, vectors, and host cells for producing such a histidine-tagged, modified IMPDH  polypeptide, and to kits comprising the histidine-tagged, modified IMPDH polypeptide.
Patent CA-2493353-A1 (CA)
Title: Protective sports garment
Inventor: FARRELL DANIEL P
IPC: A41D13/05
Filed: 2001-08-13
Abstract: A continuous protective garment (10) provides a matrix of cells (12) each containing a cube-like protective element. Continuous layers of fabric (24) bonded along intersecting lines provides an individual cell for each of plural protective element (20) sandwiches between the fabric layers (24). An outer rigid protective surface (30) of each protective element (20) absorbs externally applied forces, while a middle cushioning layer (32) provides dispersion and buffering of such externally applied forces. An innermost layer (34) of a fluid-resistant material helps prevent perspiration from being absorbed, while a ventilation hole (36) through the center of each protective element (20) provides air circulation without compromising protective qualities, a substantially continuous array of cells containing the protective elements provides comprehensive surface coverage over the torso and arms of the wearer.
Patent CA-2493450-A1 (CA)
Title: Method and device for interposing an optical component between two optical fibres
Inventor: MOY JEAN-PIERRE
IPC: G02B6/26
Filed: 2003-07-18
Abstract: The invention relates to a method and a device for interposing an optical component between two optical fibres provided with lenses (3, 4) on the ends thereof. The inventive method consists in perforating a support (6) in such a way that it is possible to fix a capillary tube (7) whose inner diameter enables an optical fibre to slip therein, fixing the capillary tube (7) to the perforation (8) of the support (6), embodying a blind notch in the support (6) and the capillary tube (7) in such a way that said capillary tube (7) is divided into two parts (7a, 7b), the first flat surface (11) of the notch (10) being perpendicular to the longitudinal axis (5) of the capillary tube (7), arranging the component (12) on the first flat surface (11) and in introducing an optical fibre (1,2) into each part (7a, 7b). The inventive device comprises a support with the capillary tube (7) transversally fixed thereto. The support (6) is provided with a notch (10) in such a way that the capillary tube (7) is divided into two parts (7a, 7b). The notch (10) has the first flat surface (11) which is perpendicular to the longitudinal axis (5) of the capillary tube (7). The component is arranged on said first flat surface (11).
Patent CA-2496802-A1 (CA)
Inventor: KOBAYASHI HISATAKA
IPC: A61K49/08
Filed: 2002-08-29
Abstract: Small dendrimer-based MRI contrast agents are disclosed to accumulate in renal tubules. The accumulation enables visualization of renal structure and function, permitting assessment of structural and functional damage to the kidneys. In a disclosed embodiment, six, small dendrimer-based MRI contrast agents were synthesized, and their pharmacokinetics, whole body retention, and renal MRI images were evaluated in mice. Suprisingly, despite having unequal renal clearance properties, all of the dendrimer agents clearly visualized the renal anatomy and proximal straight tubules of the mice better than Gd-~DTPA~-dimeglumine. Dendrimer conjugate contrast agents prepared from PAMAM-G2D, DAB-G3D, and DAB-G2D dendrimers were excreted rapidly and may be acceptable for use in clinical applications.
Patent CA-2498275-A1 (CA)
Inventor: MORGAN ROSS TINA
IPC: A61P25/00
Filed: 2003-09-05
Abstract: L'invention concerne de nouveaux dérivés de 1,3,8-triazaspiro[4.5]decan-4-one à substitution hydroxyalkyle représenté par la formule (I) dans laquelle la totalité des variables ont été définies, ces dérivés étant utiles pour traiter des troubles et des états associés au récepteur ORL-1 accouplé à la protéine G. Plus particulièrement, ces composés sont utiles pour le traitement de maladies et d'états, tels que l'anxiété, la dépression, la panique, la démence, la manie, les troubles bipolaires, l'utilisation addictive de substances, la douleur neuropathique, la douleur aiguë, la douleur chronique, la migraine, l'asthme, la toux, la psychose, la schizophrénie, l'épilepsie, l'hypertension, l'obésité, les troubles nutritionnels, les états de manque, le diabète, l'arrhytmie cardiaque, l'irritabilité du côlon, la maladie de Crohn, l'incontinence urinaire, le dysfonctionnement des surrénales, l'attention déficitaire (ADD), l'attention déficitaire hyperactive (ADHD), la maladie d'Alzheimer, ainsi que pour améliorer la connaissance ou la mémoire et stabiliser l'humeur.
Patent CA-2498757-A1 (CA)
Title: Proline ester and preparation containing the same for percutaneous administration
Inventor: FURUISHI TAKAYUKI
IPC: A61K38/00
Filed: 2003-09-08
Abstract: A proline ester represented by the general formula (I): (I) (wherein R1 represents lower hydroxyalkyl, lower alkyl substituted by lower alkoxy, or lower alkyl substituted by lower alkoxy substituted by lower alkoxy) or a pharmaceutically acceptable salt of the ester. The proline ester (I) and pharmaceutically acceptable salt thereof are useful as a prodrug for enalaprilate, which is a medicine useful in the prevention of and treatments for, e.g., circulatory diseases such as hypertension, cardiac diseases (cardiac hypertrophy, cardiac failure, myocardial infarct, etc.), nephritis, and apoplexy. A medicine containing either of these is suitable for use as a preparation for percutaneous administration, especially an adhesive patch, from the standpoints of medicinal activity and use.
Patent CA-2499665-A1 (CA)
Title: Use of carbohydrates and compositions thereof for the treatment or prevention of diseases caused by imbalanced colon fermentation
Inventor: SIIKANEN OSMO
IPC: A23L33/10
Filed: 2003-09-16
Abstract: The present invention relates to the use of carbohydrates in the preparation of a composition for treating and/or preventing diseases and/or disorders caused by imbalanced fermentation in the colon comprising providing composition capable of maintaining a sustained and controlled fermentation throughout the colon of a subject by formulating slowly fermented complex oligomeric or polymeric carbohydrate(s) into a nutritionally, nutraceuticall y and/or pharmacologically acceptable composition. The present invention also relates to a composition comprising a slowly fermented complex oligomer or polymer carbohydrate as an active component for sustaining and controlling t he fermentation throughout the colon of a subject.
Patent CA-2502007-A1 (CA)
Title: Improved airspring assembly
Inventor: TUBBS ORAIN
IPC: B60G17/052
Filed: 2003-12-11
Abstract: An improved airspring assembly includes a collapsible support member (44) disposed within the pressurizable chamber (16) of an airspring (10) having a flexible sidewall (14). The support member (44) is configured such that it extends and collapses along a longitudinal axis of the chamber (16) responsive to pressurization and depressurization of the chamber (16), respectively. The support member (44) also is configured such that it retains a substantially rigid outer perimeter, thereby restricting movement of the chamber's flexible sidewall (14) toward the longitudinal axis when the chamber (16) is depressurized. The support member (44) also is configured such that it does not interfere with the full stroke of the airspring (10).The support member (44)is configured as a helical spring (44).
Patent CA-2503530-A1 (CA)
Inventor: WANG WEIZHENG
IPC: H04B1/707
Filed: 2003-10-10
Abstract: A method and apparatus for transmitting and receiving a coded signal having an upper layer signal (130) and a lower layer signal (1312) is disclosed. The method comprises the steps of combining the upper layer signal and the lower layer signal, encoding the combined upper layer signal and lower layer signa l, delaying the upper layer signal, modulating the delayed upper layer signal, modulating the lower layer signal, transmitting the delayed upper layer sign al and transmitting the lower layer signal. The apparatus comprises an encoder (1301), for encoding a combined upper layer signal and lower layer signal, a delay communicatively coupled to the encoder, for delaying the upper layer signal, a first modulator, for modulating the upper layer signal, a second modulator, for modulating the lower layer signal, a transmitter (1314), communicatively coupled to the first modulator, for transmitting the delayed upper layer signal, and a second transmitter (13, 16), communicatively coupl ed to the second modulator.
Patent CA-2506961-A1 (CA)
Title: Core biopsy device
Inventor: VANDER VEEN MARK
IPC: A61B10/04
Filed: 2005-05-10
Abstract: A core biopsy device comprises an outer cutting cannula in telescoping register with an inner spoon cannula. The outer cutting cannula is provided at a distal end with an arcuate excising blade that is biased radially inwardly to extend beyond the longitudinal axis of the cannula. The inner spoon cannula terminates at a distal end in an arcuate wall to form a biopsy sample spoon for supporting a biopsy sample thereon. The outer cutting cannula can be rotated relative to the inner spoon cannula so that the excising blade can excise the biopsy sample from the surrounding tissue. After removal of the core biopsy device from the tissue, the outer cutting cannula can be retracted away from the inner spoon cannula to reveal the biopsy sample and enable the sample to be removed from the biopsy device in a relatively undisturbed condition.
Patent CA-2507485-A1 (CA)
Title: Procede et installation de dessalement d'eau salee
Inventor: VAN ELS HANS JOSEF
IPC: F24S90/00
Filed: 2003-11-26
Abstract: L'invention concerne un procédé et une installation de dessalement d'eau salée. Selon ce procédé, l'eau salée passe par un échangeur de chaleur implanté dans un bassin contenant de la saumure puis l'eau salée qui a été chauffée dans l'échangeur de chaleur, passe par un évaporateur destiné à l'évaporation d'au moins une partie de cette eau salée. Ensuite la vapeur ainsi obtenue est introduite dans un condenseur de manière à obtenir de l'eau de laquelle le sel a été enlevé. L'installation de dessalement de l'eau salée comprend un bassin contenant une saumure et abritant un échangeur de chaleur, des moyens d'alimentation en eau à dessaler étant connectés à une entrée de l'échangeur de chaleur et une entrée de l'évaporateur étant connectée à une sortie de l'échangeur de chaleur, tandis qu'une sortie de l'évaporateur est connectée au moyen de condensation de la vapeur d'eau formée dans l'évaporateur.
Patent CA-2509691-A1 (CA)
Inventor: PARK EDWARD HOSUNG
IPC: B29C47/00
Filed: 2005-06-10
Abstract: Methods for making processable rubber compositions containing fluorocarbon elastomers cured by polyol or phenol curative agents include an optional heat treating step before thermoplastic processing. In one aspect, a dynamic vulcanizate of a fluorocarbon elastomer containing an excess of un-reacted polyol curative agent is subject to a pre-molding heat treatment at a temperature of 150°C or above, but preferably below the thermoplastic processing temperature, for a time sufficient to drive off or decompose at least part of the un-reacted or excess polyol curative agent. After part or all of the curative agent is driven off or decomposed by the heat treatment, the heat treated material may be thereafter processed by thermoplastic techniques to form shaped articles. Advantageously, articles produced by thermoplastic processing of the heat treated dynamic vulcanizates are characterized by a low permeability to gases and vapors.
Patent CA-2510510-A1 (CA)
Title: Ceramic balance beads and method of tire balancing
Inventor: KRUEGER ROBERT L
IPC: F16F15/32
Filed: 2005-06-22
Abstract: A container 10 is filled with ceramic balancing beads 20. The container is held closed by a removable clip 15, 16 or a mild adhesive 14. The beads are high density and therefore low in volume with regular surfaces, spherical or ellipsoid, for moving smoothly over one another. The container 20 self-opens when impact forces overcome the mild adhesive.
Patent CA-2511168-A1 (CA)
Title: Screened gravity-fed funnel
Inventor: KIEFER JOHN W
IPC: B01D35/05
Filed: 2005-06-29
Abstract: A screened gravity-fed water funnel or water funnel kit may be characterized in one aspect as including a substantially conically-shaped water-permeable mesh screen, a funnel releasably mounted or mountable to, and in fluid cooperation with, the screen, and a flexible tether mounted or mountable to the screen. An anchor or other means for embedding m upstream end of the tether immobile in the stream is mounted or mountable to the tether, opposite to the screen. That is, the anchor is mounted or mountable at an upstream end of the tether and an upstream narrow end of the screen is mounted or mountable to a downstream end of the tether, and wherein an upstream wide-end of the funnel is mounted to a downstream wide-end of the screen, and wherein a hose coupler is mounted or mountable to a downstream narrow end of the funnel.
Patent CA-2512798-A1 (CA)
Title: Fluorescence based t-type channel assay
Inventor: JANKE DIANA
IPC: G01N33/68
Filed: 2004-01-07
Abstract: A fluorescence based assay for compounds that modulate T-type calcium ion channels and that can be adapted to high throughput screening formats.  Modulators of T-type channels are useful to correct functional abnormalities.  These abnormalities are associated with epilepsy, pain, schizophrenia, depression, anxiety, cardiac arrhythmia, hypertension, certain types of cancer, diabetes, infertility, sexual dysfunction and other undesirable conditions.
Patent CA-2516064-A1 (CA)
Title: Liquid electrolyte for an electrochemical cell, electrochemical cell and implantable medical device
Inventor: SCHMIDT CRAIG L
IPC: A61N1/378
Filed: 2004-02-12
Abstract: A liquid electrolyte for use in an electrochemical cell having an alkali metal anode is provided. The liquid electrolyte comprises an additive formed of at least one selected from the group comprising: a tautomer; an alcohol having the formula R-OH, where R is one selected from the group comprising an unsaturated carbon chain having at least two carbon atoms, a saturated carbon chain having at least one carbon atom, and an aromatic carbon chain; a sugar;  and an acid selected from the group comprising nitric acid, sulfuric acid and sulfuric acid partially substituted with an ion of said alkali metal material.
Patent CA-2517847-A1 (CA)
Title: Thiadibenzoazulene derivatives for the treatment of inflammatory diseases
Inventor: MERCEP MLADEN
IPC: A61P29/00
Filed: 2004-03-05
Abstract: The present invention relates to novel 1-thia-dibenzoazulene derivatives of the formula (I), wherein X individually denotes a hetero atom -O- or -S-; Y  and Z independently from each other individually denote a fragment of the formula (II) to their pharmacologically acceptable esters, salts and solvates, to processes and intermediates for the preparation thereof, to a process for preparing pharmaceutical formulations for the treatment of inflammatory diseases and conditions and to the use thereof in the treatment of inflammatory diseases and conditions in humans and animals. These compounds inhibit tumour necrosis factor-.alpha.(TNF-(.alpha.) production and interleukin-1 (IL-1) production and exhibit an analgetic action.
Patent CA-2517900-A1 (CA)
Title: Minimizing security holdings risk during portfolio trading
Inventor: DOMOWITZ IAN
IPC: G06Q40/06
Filed: 2004-03-03
Abstract: A method and computer program product for minimizing short-term risk to a portfolio of securities holdings during implementation of executing an outstanding trade list of securities to be traded, takes into account covariances between securities in the outstanding trade list and between securities in the outstanding trade list and securities in the portfolio of holdings so as to minimize risk to the portfolio of holdings as well as to a residual trade list of unexecuted orders during said implementation.
Patent CA-2518746-A1 (CA)
Title: Method and compositions for improving animal health
Inventor: CAMARGO-PEREZ GERARDO
IPC: A23K1/00
Filed: 2004-03-18
Abstract: Products as well as methods for reducing plaque in a domestic animal are provided. The product comprises retorted milk.